Cargando…
P116. The impact of neoadjuvant hormone monotherapy in deferral of surgery during the SARS-COV-2 pandemic
Autores principales: | Topping, Jonathan, Zabkiewicz, Catherine, Holland, Phillip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096304/ http://dx.doi.org/10.1016/j.ejso.2021.03.120 |
Ejemplares similares
-
The rate of patient deferral and barriers to going forward with elective orthopaedic surgery during the COVID-19 pandemic
por: Clement, Nicholas D., et al.
Publicado: (2020) -
Perioperative management of non-deferrable oncologic surgeries during COVID-19 pandemic in Madrid, Spain. Is it safe?()
por: Galipienzo, J., et al.
Publicado: (2022) -
Blood donor deferrals: Can this be reduced?
por: Jashnani, Kusum D., et al.
Publicado: (2011) -
Are deferrable the mobility impairments in older aging?
Publicado: (2016) -
Comments on: perioperative management of non-deferrable oncologic surgeries during COVID-19pandemic in Madrid, Spain. Is it safe?()
por: Sabate Pes, A.
Publicado: (2022)